Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

Aart Jan van der Lely(Erasmus University Rotterdam), R. Kent Hutson(University of Tennessee at Knoxville), Peter Trainer(The Christie Hospital), G. M. Besser(St Bartholomew's Hospital), Ariel L. Barkan(Ann Arbor VA Medical Center), Laurence Katznelson(Massachusetts General Hospital), Anne Klibanski(Massachusetts General Hospital), Vivien Herman-Bonert(Cedars-Sinai Medical Center), Шломо Мелмед(University of Virginia), Mary Lee Vance(Columbia University), Pamela U. Freda(Queen Elizabeth Hospital Birmingham), Paul M. Stewart(The University of Texas MD Anderson Cancer Center), Keith Friend(University of North Carolina at Chapel Hill), David R. Clemmons(Sahlgrenska University Hospital), Gudmundur Johannsson(Sahlgrenska University Hospital), Stavros Stavrou(Columbia University Irving Medical Center), David M. Cook(Oregon Health & Science University), Lawrence S. Phillips(Emory University), Christian J. Strasburger(Ludwig-Maximilians-Universität München), Suzanne Hacker, Kenneth Zib, Robert J. Davis, John A. Scarlett, Michael O. Thorner(University of Virginia)
The Lancet
November 1, 2001
Cited by 641

Abstract


Related Papers

No related papers found

Powered by citation graph analysis